PE firms have been selling stakes in themselves for as long as they’ve existed. The invasion of first-time funds into Asia creates extra opportunities for LPs keen to participate in GP economics
Having a third party in the capital structure of a PE fund manager can be a deal breaker for some LPs. This knowledge didn't stop CVC Capital Partners and Providence Equity Partners selling stakes in themselves...
Chinese gene therapy specialist Exegenesis Bio has received $20 million in Series B funding led by Legend Capital. It will be used to support clinical development of the company’s drug portfolio.
Alibaba Group has led a $300 million round for Chinese electric vehicle (EV) manufacturer Xpeng Motors. It comes barely two weeks after the company closed an extended Series C round of $500 million.
EDBI, the investment arm of Singapore’s Economic Development Board, has invested in Vesta, a US-based fraud and payment technology start-up with ambitions to expand into Asia.
Hana Financial has invested KRW100 billion ($85 million) in a portfolio of Korean waste to energy (WTE) projects controlled by Global Infrastructure Partners (GIP).